atrinositol has been researched along with thromboxane b2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennett, A; Cassuto, J; Jönsson, A; Nellgård, P; Tarnow, P; Tavares, IA | 1 |
| Chung, KH; Hong, JT; Kang, WS; Kim, Y; Lee, CK; Lee, MK; Ryu, CK; Yoo, HS; Yuk, DY; Yun, YP | 1 |
2 other study(ies) available for atrinositol and thromboxane b2
| Article | Year |
|---|---|
Effects of D-myo-Inositol-1,2,6-triphosphate on eicosanoid formation in burned skin.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Burns; Eicosanoids; Indomethacin; Inositol Phosphates; Leukotriene B4; Male; Prostaglandins E; Rats; Rats, Sprague-Dawley; Skin; Thromboxane B2 | 1996 |
Antithrombotic and antiplatelet activities of 2-chloro-3-[4-(ethylcarboxy)-phenyl]-amino-1,4-naphthoquinone (NQ12), a newly synthesized 1,4-naphthoquinone derivative.
Topics: Animals; Blood Coagulation; Blood Platelets; Disease Models, Animal; Fibrinolytic Agents; Inositol Phosphates; Male; Mice; Mice, Inbred ICR; Naphthalenes; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pulmonary Embolism; Rats; Rats, Sprague-Dawley; Thromboxane B2 | 2000 |